In this episode of Bearstone Insights podcast hosted by Andrew De Roy, together with Marguerite Arnold and Francis Scanlan we look into the European cannabis business. We discuss the situation in Europe in general for entrepreneurial companies in terms of access to capital and opportunities to raise money. Our guests are sharing their knowledge and experience from the perspective of cannabis business start-ups.
There is a clear interest in the European market coming from investors around the globe. Equity funds, high-net-worth individuals and especially family offices are open to take risks in the green business. Start-ups are in a position to choose, as there is no shortage in the cooperation offers.
The following questions are being debated:
- How accessible is capital in Europe for cannabis business?
- What types of investors are more keen to supply capital and take risks?
- Where to look for such an investor on the European cannabis market?
- What would make the start-up attractive to the investor?
- How to choose an investor in order to have the most rewarding cooperation?
Marguerite Arnold is an American expat and entrepreneur who has covered the legal cannabis industry globally, from Europe, since 2014. She is also launching a digital health startup called MedPayRx across Europe starting in Germany.
Meet Marguerite Arnold in person on June 27 in London during European Cannabis Week. ECW showcases the people and companies shaping the European cannabis industry. Cannabis business representatives, investors, rich discussions and quality networking are anticipated.
Dr. Francis Scanlan is the founder and Managing Director of Cloud 9 Switzerland LLC, a Health & Wellness company focused on Cannabis Edibles and Rx/OTC Pharmaceuticals. Francis has 26 years of international professional experience with increasing roles of responsibility in the Environmental, Tobacco, Phytopharmaceutical, Flavors & Food Ingredients, Food & Beverage and Wines & Spirits industries.